Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National ...
Study finds significant reductions in drinks per drinking day and alcohol craving, with potential benefits for smoking reduction Study: Once-Weekly ...
A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a ...
People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced improved quality of life, ...
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...
Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, ...
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, ...
Chronic pain is widespread in the United States, particularly among military veterans, affecting between 40 to 70% of this population ...
In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net